Aspen Aerogels (NYSE:ASPN) Price Target Raised to $25.00 at HC Wainwright

Aspen Aerogels (NYSE:ASPN) had its price target upped by HC Wainwright from $20.00 to $25.00 in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a buy rating on the construction company’s stock.

ASPN has been the topic of several other reports. TheStreet raised Aspen Aerogels from a d+ rating to a c- rating in a research report on Wednesday, March 6th. Roth Mkm restated a buy rating and set a $22.00 price target on shares of Aspen Aerogels in a research report on Tuesday, April 30th. One research analyst has rated the stock with a sell rating and six have given a buy rating to the company. According to data from MarketBeat, Aspen Aerogels has an average rating of Moderate Buy and a consensus price target of $25.17.

Aspen Aerogels Trading Up 5.3 %

NYSE ASPN opened at $25.11 on Friday. The company has a market capitalization of $1.93 billion, a price-to-earnings ratio of -57.07 and a beta of 1.97. The company has a debt-to-equity ratio of 0.24, a current ratio of 3.41 and a quick ratio of 2.91. Aspen Aerogels has a 12 month low of $5.32 and a 12 month high of $25.65. The company’s fifty day moving average price is $16.72 and its two-hundred day moving average price is $13.77.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Tuesday, February 13th. The construction company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.11. Aspen Aerogels had a negative return on equity of 6.54% and a negative net margin of 10.73%. The company had revenue of $84.22 million for the quarter, compared to the consensus estimate of $83.82 million. During the same quarter last year, the business posted ($0.20) EPS. As a group, research analysts predict that Aspen Aerogels will post 0.03 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ASPN. Federated Hermes Inc. increased its stake in shares of Aspen Aerogels by 53.9% during the fourth quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company’s stock valued at $18,211,000 after acquiring an additional 404,042 shares during the period. Rice Hall James & Associates LLC increased its position in shares of Aspen Aerogels by 385.0% during the 3rd quarter. Rice Hall James & Associates LLC now owns 623,135 shares of the construction company’s stock valued at $5,359,000 after purchasing an additional 494,662 shares during the period. Sargent Investment Group LLC increased its position in shares of Aspen Aerogels by 24.1% during the 4th quarter. Sargent Investment Group LLC now owns 337,281 shares of the construction company’s stock valued at $5,322,000 after purchasing an additional 65,571 shares during the period. Vanguard Group Inc. raised its stake in shares of Aspen Aerogels by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 3,445,887 shares of the construction company’s stock worth $29,635,000 after buying an additional 14,013 shares in the last quarter. Finally, Principal Financial Group Inc. acquired a new stake in shares of Aspen Aerogels in the third quarter valued at $449,000. 97.64% of the stock is owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.